These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 31191243)

  • 1. Cancer Stem Cells in Neuroblastoma: Expanding the Therapeutic Frontier.
    Bahmad HF; Chamaa F; Assi S; Chalhoub RM; Abou-Antoun T; Abou-Kheir W
    Front Mol Neurosci; 2019; 12():131. PubMed ID: 31191243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Stem Cells and Neuroblastoma: Characteristics and Therapeutic Targeting Options.
    Veschi V; Verona F; Thiele CJ
    Front Endocrinol (Lausanne); 2019; 10():782. PubMed ID: 31803140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XAV939 inhibits the stemness and migration of neuroblastoma cancer stem cells via repression of tankyrase 1.
    Tian X; Hou W; Bai S; Fan J; Tong H; Xu H
    Int J Oncol; 2014 Jul; 45(1):121-8. PubMed ID: 24789807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medulloblastoma cancer stem cells: molecular signatures and therapeutic targets.
    Bahmad HF; Poppiti RJ
    J Clin Pathol; 2020 May; 73(5):243-249. PubMed ID: 32034059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype analysis of tumor-initiating cells expressing CD133 in neuroblastoma.
    Cournoyer S; Nyalendo C; Addioui A; Belounis A; Beaunoyer M; Aumont A; Teira P; Duval M; Fernandes K; Fetni R; Haddad E; Sartelet H
    Genes Chromosomes Cancer; 2012 Aug; 51(8):792-804. PubMed ID: 22514116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of stemness-related molecules in neuroblastoma.
    Kamijo T
    Pediatr Res; 2012 Apr; 71(4 Pt 2):511-5. PubMed ID: 22430387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic neuroblastoma cancer stem cells exhibit flexible plasticity and adaptive stemness signaling.
    Pandian V; Ramraj S; Khan FH; Azim T; Aravindan N
    Stem Cell Res Ther; 2015 Feb; 6(1):2. PubMed ID: 25888913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroblastoma pathogenesis: deregulation of embryonic neural crest development.
    Tomolonis JA; Agarwal S; Shohet JM
    Cell Tissue Res; 2018 May; 372(2):245-262. PubMed ID: 29222693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of β-carotene on cancer cell stemness and differentiation in SK-N-BE(2)C neuroblastoma cells.
    Lee HA; Park S; Kim Y
    Oncol Rep; 2013 Oct; 30(4):1869-77. PubMed ID: 23900747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer stem cells and immunoresistance: clinical implications and solutions.
    Codony-Servat J; Rosell R
    Transl Lung Cancer Res; 2015 Dec; 4(6):689-703. PubMed ID: 26798578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer stem cells in neuroblastoma therapy resistance.
    Aravindan N; Jain D; Somasundaram DB; Herman TS; Aravindan S
    Cancer Drug Resist; 2019 Dec; 2(4):948-967. PubMed ID: 31867574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bad seed: Cancer stem cells in tumor development and resistance.
    Koren E; Fuchs Y
    Drug Resist Updat; 2016 Sep; 28():1-12. PubMed ID: 27620951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoic acid receptor β enhanced the anti-cancer stem cells effect of β-carotene by down-regulating expression of delta-like 1 homologue in human neuroblastoma cells.
    Kim YS; Kim E; Park YJ; Kim Y
    Biochem Biophys Res Commun; 2016 Nov; 480(2):254-260. PubMed ID: 27751853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current approaches in identification and isolation of human renal cell carcinoma cancer stem cells.
    Khan MI; Czarnecka AM; Helbrecht I; Bartnik E; Lian F; Szczylik C
    Stem Cell Res Ther; 2015 Sep; 6(1):178. PubMed ID: 26377541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cells: progress and challenges in lung cancer.
    Templeton AK; Miyamoto S; Babu A; Munshi A; Ramesh R
    Stem Cell Investig; 2014; 1():9. PubMed ID: 27358855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma.
    Flahaut M; Jauquier N; Chevalier N; Nardou K; Balmas Bourloud K; Joseph JM; Barras D; Widmann C; Gross N; Renella R; Mühlethaler-Mottet A
    BMC Cancer; 2016 Oct; 16(1):781. PubMed ID: 27724856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
    Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
    Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PlGF and VEGF-A Regulate Growth of High-Risk MYCN-Single Copy Neuroblastoma Xenografts via Different Mechanisms.
    Zins K; Kovatchki D; Lucas T; Abraham D
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic approaches targeting cancer stem cells.
    Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
    J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.